--Allergan, an AbbVie company, today announced that the U.S. Food and Drug Administration has approved a label expansion of BOTOX ® to include eight new muscles for the treatment of upper limb ...

This label expansion is based on two additional randomized, multicenter, double-blind, placebo-controlled studies evaluating the efficacy and safety of Botox in patients with upper limb spasticity.

The Food and Drug Administration (FDA) has expanded the approval of Botox ® (onabotulinumtoxinA) to include 8 new muscles for the treatment of upper limb spasticity in adults, along with the use ...

The FDA has approved a label expansion for Botox to include eight new muscles and the use of ultrasound for the treatment of upper limb spasticity in adults, according to a press release.Botox ...

Label updates include addition of two thumb flexor muscles and increased maximum cumulative dose DUBLIN, April 20, 2015 /PRNewswire/ -- Actavis plc (NYSE: ACT), which recently completed the ...

In the upper extremity, compartment syndromes can develop in the deltoid, brachium, antebrachium, and hand. Some enclosed, isolated muscles, such as the anconeus and quadrate pronator, may also be ...

Upper limb spasticity is a condition that affects the way you move your arms. It makes your muscles stiff and flexed. Sometimes, your arms will twitch or move in a way you can’t control, called ...

NORTH CHICAGO, Ill., July 29, 2021 /PRNewswire/ -- Allergan, an AbbVie (NYSE: ABBV) company, today announced that the U.S. Food and Drug Administration (FDA) has approved a label expansion of ...

(RTTNews) - Allergan, an AbbVie (ABBV) company, said that the U.S. Food and Drug Administration has approved a label expansion of BOTOX to include eight new muscles for the treatment of upper limb ...

For over a century, there have been medical descriptions of compartment syndrome. In 1881, Volkmann [3] first described the clinical findings of myonecrosis and contracture due to prolonged muscle ...